Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-EN Version v11-EN
Language English English
Date Updated 2018-01-04 2018-01-03
Drug Identification Number 02247946 02247946
Brand name TEVA-RAMIPRIL TEVA-RAMIPRIL
Common or Proper name RAMIPRIL RAMIPRIL
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients RAMIPRIL RAMIPRIL
Strength(s) 5MG 5MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 500 500
ATC code C09AA C09AA
ATC description ACE INHIBITORS, PLAIN ACE INHIBITORS, PLAIN
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2017-08-20 2017-08-20
Estimated end date 2017-11-30 2017-11-30
Actual end date 2018-01-03 2018-01-03
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments